Introduction of rubella-containing-vaccine to Madagascar: implications for roll-out and local elimination.

ABSTRACT: Few countries in Africa currently include rubella-containing vaccination (RCV) in their immunization schedule. The Global Alliance for Vaccines Initiative (GAVI) recently opened a funding window that has motivated more widespread roll-out of RCV. As countries plan RCV introductions, an understanding of the existing burden, spatial patterns of vaccine coverage, and the impact of patterns of local extinction and reintroduction for rubella will be critical to developing effective programmes. As one of the first countries proposing RCV introduction in part with GAVI funding, Madagascar provides a powerful and timely case study. We analyse serological data from measles surveillance systems to characterize the epidemiology of rubella in Madagascar. Combining these results with data on measles va

SUBMITTER: Wesolowski A 

PROVIDER: S-EPMC4874430 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature